Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albumin Assisted Diuresis in Decompensated Cirrhosis
NCT06812390Phase 2Recruiting
- Start
- Feb 2025
- Primary completion
- Dec 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in decompensated cirrhosis, ascites and peripheral edema comparing Albumin first with Placebo first (2 arms). Primary endpoint: Change in fractional excretion of sodium at 6 hours. Started Feb 2025; status: recruiting.
02
Drugs
albumin (human)
03
Conditions
decompensated cirrhosisascitesperipheral edema
Beyond the preview
Go deeper on NCT06812390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06812390.